Periodic Reporting for period 1 - ASSERT (Development of a nanotechnology-based innovative assay for the diagnosis of allergy to Betalactams)

Allergy to betalactam antibiotics such as amoxicillin, is a worldwide problem affecting more than 10% people, partly due to high consumption. It is a burden for patients that must take less effective and more expensive second-line antibiotics and must stay longer at the...